Pricing Log in Create free account

Bone Biologics Corp. (BBLG) vs Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX)

Bone Biologics Corp. and Biodexa Pharmaceuticals PLC Unsponsored ADR are both Biotechnology companies. Biodexa Pharmaceuticals PLC Unsponsored ADR is the larger, with a market value of $1.3M against $1.1M — 1.1× the size. Bone Biologics Corp. has the higher net margin (0.00% vs −1,155.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 8 metrics below, Biodexa Pharmaceuticals PLC Unsponsored ADR leads on 5 and Bone Biologics Corp. on 3.

Valuation

Metric BBLG BDRX Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.20 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.20 0.66
EV/Sales n/m (2.81) 9.02
Earnings yield (438.22%) (102.95%) (32.88%)
Free cash flow yield (214.89%) 0.00% (23.13%)

Profitability

Metric BBLG BDRX Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (1,155.70%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (47.49%) 0.00% (51.96%)
Return on assets (44.46%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BBLG BDRX Biotechnology median
Revenue growth (TTM) — 60.22% 6.76%
EPS growth (last fiscal year) 90.85% 89.62% 29.88%
Revenue growth, 5-year CAGR — (28.78%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BBLG BDRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.38 2.41 4.97
Net debt to EBITDA 1.65 1.00 1.01

Dividend

Metric BBLG BDRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BBLG BDRX Biotechnology median
Market cap 1.10m 1.25m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack